X-ray therapy systems developer Xstrahl announced the launch of the new SARRP (small animal radiation research platform) beamline pre-clinical radiation research and computed tomography (CT) imaging platform. The system was launched at the 2019 International Congress of Radiation Research (ICRR), Aug. 25-29 in Manchester, U.K.
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k) clearance for treatment of skin cancer. The Photoelectric Therapy System is a compact and ergonomic superficial X-ray therapy system operating in the 10kV to 80kV range intended for superficial radiotherapy and surface electronic brachytherapy treatment of primary malignant epithelial neoplasms of the skin and keloids.
November 4, 2010 – A new control system for an X-ray therapy system was unveiled at the American Society for Radiation Oncology (ASTRO) meeting in San Diego, Calif. Imperium, by Xstrahl, provides an easy-to-use clinical interface to help streamline the administrative aspect of patient care.